Perfluorohexyloctane

(Miebo®)

Miebo®

Drug updated on 11/17/2023

Dosage FormOphthalmic solution (topical: 100% perfluorohexyloctane)
Drug ClassSemifluorinated alkane
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • Indicated for the treatment of the signs and symptoms of dry eye disease (DED).

Product Monograph / Prescribing Information

Document TitleYearSource
Miebo (perfluorohexyloctane) Prescribing Information. 2023Bausch & Lomb Americas Inc., Bridgewater, NJ

Systematic Reviews / Meta-Analyses